Protagonist Therapeutics Inc. (PTGX) Stock Holdings & Institutional Ownership

Protagonist Therapeutics Inc.

PTGX

Super Fund	Position	Shares	Curr. Value	Port. %	Activity
Farallon Capital Management	Equity	6,196,006	$411,600,679	2.33%	+0.39%
Duquesne Family Office	Equity	159,700	$10,609,000	0.27%	+100%
Polen Capital Management	Equity	20,325	$1,350,190	0.00%	+27.04%

Total Shares Held: 6,376,031

Total Value Reported: $423,559,869

Average Allocation per Portfolio 0.87%

Largest Single Portfolio Allocation: 2.33%

Largest Shareholder: Farallon Capital Management

Change in Total Shares Held (Q on Q): +188,026

Percentage Change in Shares Held (Q on Q): 3.04%

Number of Current Holders: 3

Number of New Holders (Q on Q): 1

Number of Funds with Additions (Q on Q): 3

Number of Funds with Reductions (Q on Q): 0

Number of Funds Fully Divested (Q on Q): 0

Number of Funds with No Change (Q on Q): 0